Rev Bras Oftalmol.2015;74(4):201-202
Triamcinolone for diabetic retinopathy
DOI: 10.5935/0034-7280.20150041
The current therapeutic approach to diabetic retinopathy, based on the high level of scientific evidence, includes drugs administered via intraocular injection into the vitreous cavity associated or not to laser photocoagulation of the retina, besides a multidisciplinary approach for systemic metabolic control. The treatment is indicated in the proliferative form of the disease and/or diabetic macular edema (the main cause of visual loss).The ETDRS – Early Treatment Diabetic Retinopathy Study – has defined the laser treatment strategies in the diabetic retinopathy according to the classification, assessing the effects of panphotocoagulation at earlier stages and macular photocoagulation for macular edema1,2 […].